AVPR1B
MOLECULAR TARGETarginine vasopressin receptor 1B
AVPR1B (arginine vasopressin receptor 1B) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting AVPR1B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Vasopressins Antidiuretic hormones released by | 3.71 | 40 |
| 2 | Arginine Vasopressin | 3.33 | 27 |
| 3 | desmopressin | 3.14 | 22 |
| 4 | Oxytocin | 2.71 | 14 |
| 5 | atosiban | 2.40 | 10 |
| 6 | Deamino Arginine Vasopressin | 1.79 | 5 |
| 7 | nelivaptan | 1.79 | 5 |
| 8 | Ornipressin | 1.10 | 2 |
| 9 | 2-Chloroadenosine 2-Chloroadenosine. | 0.69 | 1 |
| 10 | Lypressin | 0.69 | 1 |
About AVPR1B as a Drug Target
AVPR1B (arginine vasopressin receptor 1B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented AVPR1B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
AVPR1B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.